FDA Import Refusal SCS-7464088-5/10003/1 — AASHISH AKBAR BHARWANI
The FDA refused shipment SCS-7464088-5/10003/1 from AASHISH AKBAR BHARWANI (India) on Feb 17, 2026. The refused product falls under Drugs and Biologics — GLIMEPIRIDE (ANTI-DIABETIC). Cited charges: 118,75 This firm has 3 other import refusals on record.
Refusal Details
- Date
- Feb 17, 2026
- Country
- India
- Product Category
- Drugs and Biologics
- Product Code
- 61PDA31 GLIMEPIRIDE (ANTI-DIABETIC)
- Charges
- 118,75